Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



PIMSTONE SIMON N. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/02/2023 4 PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 18,475 options to buy @ $38.96, valued at $719.8k
06/01/2023 4 PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Sold 18,006 shares @ $38.63, valued at $695.6k
Sold 19,000 shares @ $39.9, valued at $758.1k
Sold 12,000 shares @ $38.53, valued at $462.4k
Exercised 29,835 shares @ $9.85, valued at $293.9k
Paid exercise price by delivering 6,165 shares @ $38.37, valued at $236.6k
Sold 23,670 shares @ $38.81, valued at $918.6k
Paid exercise price by delivering 23,144 shares @ $38.37, valued at $888k
Sold 26,856 shares @ $38.69, valued at $1M
Paid exercise price by delivering 1,860 shares @ $38.53, valued at $71.7k
Sold 7,458 shares @ $38.97, valued at $290.6k
Paid exercise price by delivering 20,745 shares @ $38.53, valued at $799.3k
03/09/2023 4 PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Exercised 41,152 shares @ $2.68, valued at $110.3k
Paid exercise price by delivering 2,160 shares @ $37.13, valued at $80.2k
Sold 10,990 shares @ $37.01, valued at $406.7k
Exercised 30,864 shares @ $2.59, valued at $79.9k
Paid exercise price by delivering 1,618 shares @ $37.13, valued at $60.1k
Sold 8,242 shares @ $36.94, valued at $304.5k
Exercised 41,152 options to buy @ $0
Exercised 30,864 options to buy @ $0
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2021 4 PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Sold 17,557 shares @ $31.33, valued at $550.1k
05/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/24/2020 4 PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Disposed of 45,000 shares @ $0
06/02/2020 4 PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Sold 5,000 shares @ $13.99, valued at $70k
Sold 3,000 shares @ $14.43, valued at $43.3k
05/28/2020 4 PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Exercised 6,172 shares @ $3.56, valued at $22k
Paid exercise price by delivering 1,108 shares @ $14.9, valued at $16.5k
Exercised 6,172 options to buy @ $0
03/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/24/2019 4 PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Sold 10,395 shares @ $9.51, valued at $98.9k
09/18/2019 4 PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Exercised 36,008 shares @ $3.7, valued at $133.2k
Paid exercise price by delivering 10,769 shares @ $9.44, valued at $101.7k
Exercised 9,259 shares @ $3.07, valued at $28.4k
Paid exercise price by delivering 2,769 shares @ $9.44, valued at $26.1k
Exercised 12,345 shares @ $3.38, valued at $41.7k
Paid exercise price by delivering 3,692 shares @ $9.44, valued at $34.9k
Granted 280,000 options to buy @ $9.44, valued at $2.6M
Exercised 36,008 options to buy @ $0
Exercised 9,259 options to buy @ $0
Exercised 12,345 options to buy @ $0
03/14/2018 4 PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Exercised 10,288 shares @ $3.77, valued at $38.8k
Exercised 10,288 options to buy @ $0
03/13/2018 4 PIMSTONE SIMON N. (CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 140,000 options to buy @ $4.75, valued at $665k
10/24/2017 4 PIMSTONE SIMON N. (President & CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 11,000 options to buy @ $3.1, valued at $34.1k
08/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
08/02/2016 4 PIMSTONE SIMON N. (President & CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Exercised 12,345 shares @ $3.3, valued at $40.7k
Paid exercise price by delivering 4,703 shares @ $7.46, valued at $35.1k
Exercised 12,345 options to buy @ $0
03/11/2016 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy